Cargando…
Exosomes in pathogenesis, diagnosis, and treatment of pulmonary fibrosis
Pulmonary fibrosis (PF) is a group of interstitial lung diseases that seriously endanger human life and health. Despite the current advances in research on the pathogenesis and treatment of PF, the overall quality of survival and survival rates of PF patients remain low, prompting the search for mor...
Autores principales: | Yang, Yang, Liu, Yufei, Chai, Yilu, Liu, Ke, Hu, Wei, Zhao, Keni, Zhu, Yi, Gao, Peiyang, Huang, Qingsong, Zhang, Chuantao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453030/ https://www.ncbi.nlm.nih.gov/pubmed/36091791 http://dx.doi.org/10.3389/fphar.2022.927653 |
Ejemplares similares
-
Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer
por: Zhu, Yi, et al.
Publicado: (2022) -
Exosomes in liver fibrosis: The role of modulating hepatic stellate cells and immune cells, and prospects for clinical applications
por: Liu, Yufei, et al.
Publicado: (2023) -
Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis
por: Yang, Yongfeng, et al.
Publicado: (2022) -
Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
por: Mei, Qianru, et al.
Publicado: (2022) -
Efficacy and safety of glycyrrhizic acid preparation treating comorbid liver injury in COVID-19: A systematic review
por: Liu, Xu, et al.
Publicado: (2022)